6505--Acyclovir Capsules (VA-25-00048078)

Active

Contract Opportunity

Continuation of SF-1449, Block 3:

The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period.

Contract Award/Effective Date: ___________________

Implementation Period: __________________________

Ordering Period (Base Year): _____________________

Offerors shall not enter information into the above fields.

Continuation of SF-1449, Blocks 19 through 24:

To be considered for award, offerors must submit a price for line items 1 and 2 for the base year and all four option years. One award will be made in the aggregate for line items 1 and 2 for the base year and all four option years. Offered prices shall not exceed two decimal places.

Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application

Line Item 1

Acyclovir 200MG Capsules, 100 Capsules per Bottle

NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
3,256
Bottles
Option Year One
3,256
Bottles
Option Year Two
3,256
Bottles
Option Year Three
3,256
Bottles
Option Year Four
3,256
Bottles






Line Item 2

Acyclovir 200MG Capsules, 500 Capsules per Bottle

NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
15,475
Bottles
Option Year One
15,475
Bottles
Option Year Two
15,475
Bottles
Option Year Three
15,475
Bottles
Option Year Four
15,475
Bottles

Attachments/Links